Unnecessary use of Remdesivir can cause more harm than good, said Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS) in New Delhi. One of India’s leading medical experts, Dr Guleria, appealed to the public to avoid hoarding oxygen cylinders and Remdesivir injections.
The solidarity trial on anti-viral drug Remdesivir by the World Health Organisation (WHO) was a negative study, said Dr Randeep Guleria. This study stated that Remdesivir can neither reduce hospital stay nor save the life of a coronavirus patient, he said.
Dr Guleria went on to say that a study conducted in the US stated that Remdesivir can reduce hospital stay in moderate-severe cases of Covid-19.
People have started hoarding injections like Remdesivir and oxygen cylinders at home, anticipating infections, said Dr Guleria. He goes on to add, “Remdesivir is not a magic bullet.”
You do not need Remdesivir in mild cases of infection, Dr Randeep Guleria advised the public. “Patients self-isolating at home do not need Remdesivir if their oxygen saturation is above 94,” he added. The Director of AIIMS-Delhi made the statement while referring to the demand for Remdesivir injections which has skyrocketed over the past few weeks in light of the second wave of Covid-19 infections.
Remdesivir is only needed in hospitals in the case of mild-severe infections when a patient’s oxygen saturation falls below 93, he said.
Dr Randeep Guleria, addressing a roundtable of doctors on Sunday, said coronavirus is a viral infection in 85 per cent to 90 per cent of cases. A majority of patients can isolate themselves at home and recover and there will be no need for hospitalisation, steroids, Remdesivir or oxygen cylinders, he added.